Raymond James & Associates’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-11,621
| Closed | -$545K | – | 3678 |
|
|
2019
Q4 | $545K | Sell |
11,621
-4,056
| -26% | -$190K | ﹤0.01% | 2652 |
|
|
2019
Q3 | $371K | Buy |
15,677
+4,587
| +41% | +$109K | ﹤0.01% | 2851 |
|
|
2019
Q2 | $333K | Sell |
11,090
-1,260
| -10% | -$37.8K | ﹤0.01% | 2925 |
|
|
2019
Q1 | $277K | Sell |
12,350
-3,570
| -22% | -$80.1K | ﹤0.01% | 3012 |
|
|
2018
Q4 | $290K | Buy |
+15,920
| New | +$290K | ﹤0.01% | 2886 |
|